• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMJ Open . Access to and utilisation of COVID-19 antigen rapid diagnostic tests (Ag-RDTs) among the general population in Phnom Penh: a cross-secti

tetano

Editor, Senior Moderator
BMJ Open


. 2024 Dec 9;14(12):e084555.
doi: 10.1136/bmjopen-2024-084555. Access to and utilisation of COVID-19 antigen rapid diagnostic tests (Ag-RDTs) among the general population in Phnom Penh: a cross-sectional study

Kennarey Seang[SUP] 1 [/SUP], Florian Vogt[SUP] 2 3 [/SUP], Sovathana Ky[SUP] 4 [/SUP], Vichea Ouk[SUP] 4 [/SUP], John Kaldor[SUP] 2 [/SUP], Andrew John Vallely[SUP] 2 [/SUP], Vonthanak Saphonn[SUP] 5 [/SUP]



Affiliations
Abstract

Objectives: Globally, there is a lack of evidence regarding access to and utilisation of antigen rapid diagnostic tests (Ag-RDTs). This might hinder public health interventions to increase testing. We conducted a survey to understand access to and utilisation of COVID-19 Ag-RDT among residents in Phnom Penh, Cambodia.
Design: This is a representative household survey using linear regression models with random effects to account for clustering and a logistic model with random effects to assess factors associated with Ag-RDT access.
Setting: We conducted the study in 10 villages in Phnom Penh between August and mid-September 2022.
Participants: We enrolled one member per household (n=280), aged between 18 and 65 years.
Outcome measures: Both access and utilisation were defined at the individual level (self-reports). We defined access as having undergone COVID-19 rapid testing within 6 months and utilisation as having administered this test (to themselves or others) within 12 months, prior to the study interview.
Results: In a clustering-adjusted linear model, access to Ag-RDTs among the general population from the 10 villages was 34% (n=95) and utilisation was 28% (n=77). Price and advice from the pharmacist were commonly reported to be the main selection criteria for Ag-RDTs, with 41% (n=111) and 62% (n=175), respectively. In the logistic model, those with higher educational attainment were more likely to have access to the Ag-RDT compared with those with lower education levels (adjusted OR4.42, 95% CI 1.82 to 10.74).
Conclusions: Unfamiliarity with Ag-RDT tests and low education levels negatively affect access and utilisation of Ag-RDTs among the general population in Phnom Penh.

Keywords: Behavior; COVID-19; EPIDEMIOLOGIC STUDIES; EPIDEMIOLOGY; PUBLIC HEALTH.

 
Back
Top Bottom